Our columnists crack open the murky world of finance and investments
Mark Mobius’s successor on Templeton Emerging Markets has overhauled the portfolio. Is it enough to revive the former stalwart?
Gavin Lumsden assesses progress in Citywire’s Top Trusts portfolio and explains why he's looking for investment trusts trading on cheap discounts.
Sherborne Investors won its battle for seats at Electra's board without telling investors what it wanted to do. Now we will find out.
The merits of active funds over passives generate lots of column inches, but there are more important investment decisions to make.
The heavily discounted Qatar Investment Fund shoots to the top of our 'expensive' table after securing its future with an unusual share offer.
Renewables infrastructure trusts boast stronger yields than their more mainstream peers, and James Carthew spots an opportunity.
Shares I bought for just 458p in Hutchison China Meditech are now worth more than £25 thanks to the drug firm's plans for a US listing.
James Carthew sees a discount opportunity at top-performing JPMorgan European Smaller Companies.
With the recent rally in global stock markets looking too good to be true, our stock-picking columnist is focusing on his UK stocks.
Five lessons we can learn from the 20-year record of Fidelity Moneybuilder Income and its manager Ian Spreadbury.
How will our novice fare on the markets?
Dumb Investor: 'If I do lose it all in some kind of Madoff-style scam... at least my humiliation will be public.'
Dumb Investor's latest articles
Investment Trust Insider
James Carthew shares his expert knowledge to give you the inside track on investment trusts.